학술논문

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer
Document Type
Article
Source
In Respiratory Investigation September 2019 57(5):451-459
Subject
Language
ISSN
2212-5345